OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Multiplex immune profiling reveals the role of serum immune proteomics in predicting response to preoperative chemotherapy of gastric cancer
Zhaoqing Tang, Yuan Gu, Zhongyi Shi, et al.
Cell Reports Medicine (2023) Vol. 4, Iss. 2, pp. 100931-100931
Open Access | Times Cited: 19
Zhaoqing Tang, Yuan Gu, Zhongyi Shi, et al.
Cell Reports Medicine (2023) Vol. 4, Iss. 2, pp. 100931-100931
Open Access | Times Cited: 19
Showing 19 citing articles:
Longitudinal plasma proteome profiling reveals the diversity of biomarkers for diagnosis and cetuximab therapy response of colorectal cancer
Yan Li, Bing Wang, Wentao Yang, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 9
Yan Li, Bing Wang, Wentao Yang, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 9
Comprehensive discovery and functional characterization of the noncanonical proteome
Chengyu Shi, Fangzhou Liu, Xinwan Su, et al.
Cell Research (2025)
Open Access | Times Cited: 1
Chengyu Shi, Fangzhou Liu, Xinwan Su, et al.
Cell Research (2025)
Open Access | Times Cited: 1
PPIH acts as a potential predictive biomarker for patients with common solid tumors
Jun Ye, Jianchao Ying, Hạixia Chen, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 8
Jun Ye, Jianchao Ying, Hạixia Chen, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 8
Tislelizumab plus cetuximab and irinotecan in refractory microsatellite stable and RAS wild-type metastatic colorectal cancer: a single-arm phase 2 study
Xiaojing Xu, Luoyan Ai, Keshu Hu, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 6
Xiaojing Xu, Luoyan Ai, Keshu Hu, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 6
Gastric cancer immune microenvironment score predicts neoadjuvant chemotherapy efficacy and prognosis
Shaoji Zhao, Yinan Liu, Li Ding, et al.
The Journal of Pathology Clinical Research (2024) Vol. 10, Iss. 3
Open Access | Times Cited: 4
Shaoji Zhao, Yinan Liu, Li Ding, et al.
The Journal of Pathology Clinical Research (2024) Vol. 10, Iss. 3
Open Access | Times Cited: 4
Ultra-high dose rate radiotherapy overcomes radioresistance in head and neck squamous cell carcinoma
Hong‐Shuai Li, Ruiyi Tang, Shi H, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access
Hong‐Shuai Li, Ruiyi Tang, Shi H, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access
Development and Validation of a General Clinical Model for Predicting Neoadjuvant Chemotherapy Efficacy in Locally Advanced Gastric Cancer: Evidence from Meta-Analysis and Real-World Study
Lu Wang, X. Sun, Siru Nie, et al.
Research Square (Research Square) (2025)
Closed Access
Lu Wang, X. Sun, Siru Nie, et al.
Research Square (Research Square) (2025)
Closed Access
The Role of Proteomics and Genomics in the Development of Colorectal Cancer Diagnostic Tools and Potential New Treatments
Gaurav Paraskar, Sankha Bhattacharya, Kuttiappan Anitha
ACS Pharmacology & Translational Science (2025)
Closed Access
Gaurav Paraskar, Sankha Bhattacharya, Kuttiappan Anitha
ACS Pharmacology & Translational Science (2025)
Closed Access
A liquid biomarker signature of inflammatory proteins accurately predicts early pancreatic cancer progression during FOLFIRINOX chemotherapy
Casper W.F. van Eijck, Sergio Sabroso‐Lasa, Gaby J. Strijk, et al.
Neoplasia (2024) Vol. 49, pp. 100975-100975
Open Access | Times Cited: 3
Casper W.F. van Eijck, Sergio Sabroso‐Lasa, Gaby J. Strijk, et al.
Neoplasia (2024) Vol. 49, pp. 100975-100975
Open Access | Times Cited: 3
Dual-positive gastric cancer: an extremely malignant subtype of gastric cancer with high serum alpha-fetoprotein and carcinoembryonic antigen concentrations
Weixun Xie, Chaojun Hu, Hongming Liu, et al.
Frontiers in Oncology (2025) Vol. 14
Open Access
Weixun Xie, Chaojun Hu, Hongming Liu, et al.
Frontiers in Oncology (2025) Vol. 14
Open Access
Highly sensitive and wash-free human serum albumin detection based on filtration-to-enhancement compound microsphere system
Chen Yang, Xin Zhang, Minjing Mo, et al.
Chemical Engineering Journal (2025) Vol. 514, pp. 163097-163097
Closed Access
Chen Yang, Xin Zhang, Minjing Mo, et al.
Chemical Engineering Journal (2025) Vol. 514, pp. 163097-163097
Closed Access
CCL20-CCR6 signaling in tumor microenvironment: Functional roles, mechanisms, and immunotherapy targeting
Qi Liu, Mingyuan Song, Bin Wang, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025), pp. 189341-189341
Closed Access
Qi Liu, Mingyuan Song, Bin Wang, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025), pp. 189341-189341
Closed Access
The Human Gastric Juice: A Promising Source for Gastric Cancer Biomarkers
Nayra Felípez, Sheyla Montori, Naroa Mendizuri, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9131-9131
Open Access | Times Cited: 7
Nayra Felípez, Sheyla Montori, Naroa Mendizuri, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9131-9131
Open Access | Times Cited: 7
Nivolumab plus anlotinib hydrochloride in advanced gastric adenocarcinoma and esophageal squamous cell carcinoma: the phase II OASIS trial
Jing Wu, Shilong Zhang, Shan Yu, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 2
Jing Wu, Shilong Zhang, Shan Yu, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 2
Rapid multiplex immunohistochemistry for characterizing tumor-immune microenvironment
Alisa Kimura, Takahiro Tsujikawa, Hiroki Morimoto, et al.
Heliyon (2024) Vol. 10, Iss. 13, pp. e33830-e33830
Open Access
Alisa Kimura, Takahiro Tsujikawa, Hiroki Morimoto, et al.
Heliyon (2024) Vol. 10, Iss. 13, pp. e33830-e33830
Open Access
Lovastatin-mediated pharmacological inhibition of Formin protein DIAPH1 suppresses tumor immune escape and boosts immunotherapy response
Mengyun Wan, Ji Zhou, Ning Xue, et al.
International Immunopharmacology (2024) Vol. 144, pp. 113637-113637
Closed Access
Mengyun Wan, Ji Zhou, Ning Xue, et al.
International Immunopharmacology (2024) Vol. 144, pp. 113637-113637
Closed Access
İleri yaş mide kanserli hastalarda tedavi ve post operatif sonuçlarının değerlendirilmesi
Yıldıray Dadük, Ahmet Şeker, Sabri Özdaş, et al.
Adıyaman Üniversitesi Sağlık Bilimleri Dergisi (2024), pp. 218-224
Open Access
Yıldıray Dadük, Ahmet Şeker, Sabri Özdaş, et al.
Adıyaman Üniversitesi Sağlık Bilimleri Dergisi (2024), pp. 218-224
Open Access
Integrated machine learning to predict the prognosis of lung adenocarcinoma patients based on SARS ‐COV ‐2 and lung adenocarcinoma crosstalk genes
Yanan Wu, Yishuang Cui, Xuan Zheng, et al.
Cancer Science (2024)
Open Access
Yanan Wu, Yishuang Cui, Xuan Zheng, et al.
Cancer Science (2024)
Open Access
Proteome profiling of serum reveals PSMD6 as a biomarker in breast cancer metastasis
Chen Ding, Yue Meng, Minjing Huang, et al.
Research Square (Research Square) (2023)
Open Access
Chen Ding, Yue Meng, Minjing Huang, et al.
Research Square (Research Square) (2023)
Open Access
